Summary The in vitro effects of sodium n-butyrate (butyrate) on the growth, morphology and secretion of alpha-fetoprotein (AFP) and albumin by the human heptoma cell line PLC/PRF/5 were studied. Butyrate caused a marked reduction in the growth rate, colony forming efficiency in soft agar and de novo synthesis of DNA as well as remarkable morphological changes including cell enlargement, flattening and a decreased number of nucleoli. Secretion of AFP was reduced during culture with butyrate, while that of albumin was increased. The requirement of de novo protein synthesis for the increase in albumin and decrease of AFP by butyrate was demonstrated by inhibition studies with cycloheximide. These results suggest that butyrate caused the hepatoma cells to acquire in vitro properties that are considered to be more consistent with normal liver cells.
There is an increased awareness that phasing in gene expression and the concomitant changes that it entails in cell composition, function, structure, and organization are central not only to the problem of developmental and reparative growth but also to that of neoplasia. It has been proposed that malignant transformation of eukaryotic cells results from structural changes in genetic material, loss of growth control, abnormalities in cell differentiation, or misprogramming of normal gene products (Uriel, 1979) . Moreover, gene products expressed normally only during embryonal and foetal periods are frequently reexpressed in neoplasia.
The production of AFP is often enhanced in tumour-bearing hosts, particularly with hepatocellular carcinoma (hepatoma) . While the function of AFP remains undetermined, factors regulating the genomic expression of AFP are even less understood. However, it is clear that the mechanisms controlling the expression of the AFP gene must encompass aspects of both embryonic development and neoplastic transformation (Ruoslahti, 1979) . These observations have stimulated our interest in the regulatory mechanisms of AFP gene expression.
Exposure of mouse hepatoma cells to dimethyl sulfoxide (DMSO) stimulates albumin and AFP accumulation in the medium (Higgins et al., 1983) . Similarly, changes in hepatocyte gene expression occur during treatment of rat and mouse hepatoma Correspondence: T. Nakagawa. Received 10 September 1984. cells with various differentiation-inducing agents (Higgins & Borenfreund, 1980; Schut et al., 1981; Hughes et al., 1982) . Among these agents, sodium n-butyrate (butyrate), a 4-carbon fatty acid, is of major interest, since it is a natural fermentation product of colonic bacterial flora, and a potent "differentiation agent" in some cancer cells such as colorectal tumours, erythroleukaemia and a uterine cervical cancer cell line (Tsao et al., 1983; Leder & Leder, 1975; Nozawa et al., 1983) .
We have therefore examined the effect of butyrate on AFP and albumin secretion and other phenotypic changes in a human hepatoma PLC/PRF/5-cells.
Materials and methods

Chemicals
Butyrate (Nakarai Chemical Co. Kyoto, Japan) and cycloheximide (Sigma Chemical Co. St Louis, MO.) were dissolved in distilled water. These stock solutions were stored at -20°C and diluted with the culture medium just before use. Non-essential amino acid (NEAA; I OOx) for minimal essential medium (MEM) and N-2-hydroxy ethylpiperiazine-N'-2 ethane-sulfomic acid (HEPES) were purchased from Flow Laboratories (McLean, Va.).
Cell culture Human hepatoma cell line PLC/PRF/5 (Alexander et al., 1976) Colony formation in semi-solid agar medium Colony formation in semisolid agar medium was performed as previously described (Kim et al., 1980) . Cells (2 x 104) were suspended in 0.3% agar (Difco Laboratories, Detroit, MI) in complete growth medium with various butyrate concentrations. Two-ml aliquots from these suspensions were layered on a 2ml based layer of 0.5% agar in the same medium in 60mm petri dishes. The cells were seeded in agar medium with various concentrations of butyrate. Dishes were incubated at 37°C in 5% CO2 in air for 2 weeks after which colonies containing >20 cells were counted.
Nucleic acid precursor incorporation The incorporation of [3H] thymidine (sp. act., 20 Ci mmol-1; New England Nuclear, Boston, MA) was measured during growth in the presence of butyrate; 1 iCi of [3H]thymidine per ml was added for the 3 h pulse labelling. The reaction was terminated by the addition of ice-cold PBS. Cells were harvested by trypsinization, washed with PBS and centrifuged, then precipitated with 5% trichloroacetic acid and washed with methanol as indicated. The radioactivity of NCS (AmersharmSearle, Evanston, IL.)-solubilized pellets was measured in a liquid scintillation counter (PackardInstruments) as described previously (Nakao et al., 1983 ).
AFP and albumin determinations The concentrations of AFP and albumin in the culture medium were determined by enzyme-linked immunoassays (ELISA). Media with treated or untreated cells were centrifuged (3000 g min-1) and the AFP content of the supernatant was assayed in accordance with-the instruction of KINOS Laboratories, Ink. (Tokyo, Japan). Albumin content of the supernatant was determined by ELISA using rabbit antihuman albumin and horseradish peroxidase conjugated rabbit antihuman albumin antibodies (Cappel, Cochranville, PA), as described for human AFP (Uotila et al., 1981) . The limits of detection in the ELISA were 1.0 ng/tube for both AFP and albumin. Control medium, which was not inoculated with cells, had no detectable levels of AFP or albumin.
Cell protein determination The cells were washed with PBS twice and then 1 ml of 0.08% soidum lauryl sulfate (SDS) was added to the cell layer. Protein concentration was measured by Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, Ca.) using bovine serum albumin as the standard (Bradford, 1976) . SDS at this concentration had no interfering effect on protein determination.
Effect ofprotein synthesis inhibitors A protein synthesis inhibitor cycloheximide was used to examine the de novo synthesis of AFP and albumin by the cells in the presence of butyrate. The inhibitor was added at concentrations of 0.1 and 0.5 Mg ml-1 to the culture medium with or without butyrate (Day 0). Cells were cultured on 6 well multiwell dishes for 4 days and then assayed for AFP and albumin levels in the medium and cell protein.
Morphological studies Butyrate-treated or -untreated cells were stained with Giemsa and examined for morphological changes under a light microscope. An aliquot of 2 x108 cells centrifuged at 900g was immediately fixed in a mixture of glutaraldehyde and then in 2% buffered osmium. After dehydration in ethanol, they were embedded in an epoxy resin. Ultrathin sections were examined by a JEM-1200 EX electron microscope (Japan Electron Optimal Lab., Tokyo, Japan) after uranyl and lead citrate staining (Nagasaka et al., 1983) .
Statistical analysis Data were analysed using Student's t test on paired differences.
Effect of butyrate on growth properties Butyrate caused a marked reduction in the growth rate of PLC/PRF/5 cells within 2 days (Figure 1 ). Normal growth rates were restored upon removal of butyrate. At 2 mM, butyrate had little effect on the viability of the cells as assessed by trypan blue exclusion, and suggested by the continuous increase in cell number from day 0 to day 5 in the treated cells. Furthermore, in both treated and untreated cultures there were no more than 5% floating cells. during the initial 24 h of culture. After 2 and 3 days treatment with 1.0mM butyrate, AFP levels were constantly lower compared with controls, whereas albumin levels were constantly higher than that of control cultures (data not shown). As shown in Figure 3 , AFP levels in the medium from 4 days culture were significantly decreased by 0.05 to 1.0 mM butyrate in a dose dependent manner (P<0.01), whereas albumin levels were increased to 201% of controls by 1.OmM butyrate (P<0.01) and 125% by 0.6mM butyrate.
Effects ofprotein synthesis inhibitors
The increase of albumin and decrease of AFP content in the butyrate culture medium was completely inhibited by the addition of cycloheximide (0.5 g ml -1) throughout the 4 days of the experiment (Table II) . Cycloheximide at 0.5 Mg ml1 inhibited 70% of cellular protein synthesis. Morphological changes Figure 4 shows the morphological changes of PLC/PRF/5 cells after 4 days treatment with I mM butyrate. Giemsa-staining of treated cells revealed the disappearance of the formerly prominent nucleolus, altered chromatin network, cellular change in spindle shape and the enlargement and increased number of membranous processes. These changes were confirmed by electron microscopy. Untreated cells had a dense cytoplasmic matrix with few elements of the endoplasmic reticulum and abundant polysomes and mitochondria. Sparsely distributed glycogen granules were evident. The nuclei were characterised by the absence of condensed chromatin, which was dispersed in clumps around the nucleoplasm. Most cells had more than one nucleolus. Virus particles were not detected ( Figure  Sa) . In cells treated with 1 mM butyrate the number of nucleoli was reduced, but the number of microvilli was increased. The cytoplasm contained large numbers of organelles with increased amounts of rough endoplasmic reticulum (Figure 5b ).
Discussion
These results show that butyrate caused a significant decrease in the total accumulated extracellular AFP in human hepatoma cell line PLC/PRF/5 (Figure 3 ). (Terada et al., 1978) and nuclear histone composition through acetylation (Annunziato & Seale, 1983) . After the discovery of histone acetylation (Allfrey et al., 1964) , it was suggested that this post-synthetic modification of histone structure could provide an enzymatic mechanism for modulating the interactions between histones and DNA in ways that affect the structure and function of chromatin. Furthermore, numerous correlations have been noted between increased acetylation of the histones and gene activation for RNA synthesis (Ruiz-Carrillo et al., 1975) . Thus, further study of butyrate-induced phenotypic changes in the human hepatoma cell line PLC/PRF/5 may provide useful information on the regulatory mechanisms of genes expressing differentiation-associated phenotypes in human hepatocytes and contribute to elucidation of the molecular events involved in their malignant transformation.
